Thymosin Beta-4 (Full)
Worth trying, BioHarmony verdict
BioHarmony score 6.9 out of 10
Thymosin beta-4 is the native 43-amino-acid peptide that promotes tissue repair via actin-sequestering and the Ac-SDKP repair axis. It has the cleanest Phase 1 safety profile in its class, per Ruff 2010, but most Phase 3 efficacy endpoints in dry eye missed, and US compounding access has effectively closed.
Read full reportWhat is Thymosin Beta-4 (Full)?
Thymosin beta-4 (Tβ4) is the native 43-amino-acid actin-sequestering peptide first sequenced from calf thymus by Low, Hu, and Goldstein in 1981, and it pairs the cleanest Phase 1 intravenous safety record in this class with a mixed Phase 3 efficacy profile and a narrowing access path. Its primary biochemical job is sequestering monomeric G-actin to tune cytoskeletal polymerization, which downstream drives cell migration, angiogenesis through integrin-linked kinase activation, anti-apoptotic Akt signaling, and dampened innate inflammation.
From the BioHarmony report, reviewed Sep 8, 2026.
Saved on this device only.
How it is thought to work
Sequesters monomeric G-actin to regulate cytoskeletal dynamics; promotes cell migration, angiogenesis, anti-apoptosis, and anti-inflammation; cleaved to the Ac-SDKP antifibrotic tetrapeptide
Safety watch-outs
- Active or recent cancer (within 5 years): do not use. Preclinical models and correlative human IHC data show Tβ4 promotes tumor migration…
- Pregnancy, breastfeeding, or pediatric use: avoid. No human reproductive safety data exists.
- Tested athlete subject to WADA: do not use. Banned at all times with a 30 to 45 day detection window.
- Material with no certificate of analysis, no third-party sequence confirmation, or with the label TB-500: this is the fragment, not native…
- New or worsening allergic reaction at the injection site: stop and consult a clinician.
Full risk profile in the BioHarmony report.
Dosing as published
Source-reported figures only. This page does not calculate a personal dose.
No approved-label or study protocol is recorded for Thymosin Beta-4 (Full) yet.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Educator coverage (6)
Attributed viewpoints, separate from primary research.
- International Peptide Society 2018 Compound Curriculum Dr. William Seeds,
- Stem Cells, Peptides, and the Real Reason You're Getting Old Dr. Adeel Khan,
- Muscle Building in Midlife, Joint Regeneration, Peptide Protocols, and Why Osteoarthritis Is Not Wear and Tear Dr. Elizabeth Yurth,
- Thymosin Beta-4 vs TB-500: Which Peptide is Better for Healing? Hunter Williams,
- Thymosin Beta 4 Benefits for Skin, Hair and Immunity Jay Campbell,
- BPC157: The One Stop Peptide for Body, Brain & Gut with Jean Francois Tremblay Nathalie Niddam,
Trust & sourcing
- Last revieweddone
- Next reviewupcoming
There is no FDA-approved thymosin beta-4 product. FDA prepared a July 2026 Pharmacy Compounding Advisory Committee evaluation of TB-500-related bulk drug substances, a seven-amino-acid fragment that FDA states is not the same substance as thymosin beta-4, and proposed not adding those substances to the 503A bulks list. Advisory-committee voting outcomes have not been published by FDA.
Primary sources
- FDA briefing document for TB-500-related bulk drug substances U.S. Food and Drug Administration,
- July 23-24, 2026 meeting of the Pharmacy Compounding Advisory Committee U.S. Food and Drug Administration,
- Drugs@FDA: FDA-Approved Drugs search tool, queried for "thymosin" (no approved application found) U.S. Food and Drug Administration, Drugs@FDA,
Related peptides for recovery & tissue repair
- 7.4Thymosin Alpha-1Thymosin Alpha-1 is a 28-amino-acid thymic peptide with strongest evidence in immune-compromised and hospital-adjacent settings: Cao 2024 pooled 39 acute COPD…
- 7.2GHK-Cu (Copper Peptide)GHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
- 7.1SemaxSemax is a Russian-developed ACTH 4-7 + PGP heptapeptide with the strongest human signal in post-stroke recovery, including a 110-patient Gusev et al.
- 6.7ARA-290ARA-290 (cibinetide) is an EPO-derived peptide that activates the innate repair receptor to regrow small nerve fibers without EPO's blood effects.
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.